Muscular disorder related to immune checkpoint inhibitors: forewarned is forearmed

We would like to bring to the attention of the medical community the emergence of a serious acquired muscular disorder arising from immune checkpoint inhibitors (ICIs) that are now widely used in anticancer treatment. This is of particular interest to neurologists and oncologists, as they will have a pivotal role in the management of such cases.